Cancer Vaccine Week articles from November 2008

Cancer Vaccine Week archives from November 2008

UCSB researchers develop cross-protective vaccine.
November 3, 2008... Doctors have always hoped that scientists might one day create a vaccination that would treat a broad spectrum of maladies. They could only imagine that there might be one vaccine that would protect against, say, 2,500 strains of Salmonella....

Investigators at Cork University release new data on cancer vaccines.
November 3, 2008... According to a study from Cork, Ireland, "We aimed to identify mechanisms driving local recurrence in a model of breast-conserving surgery (BCS) for breast cancer. Breast cancer recurrence after BCS remains a clinically significant, but poorly...

Research on cancer vaccines reported by J.M. Tovar et al.
November 3, 2008... According to recent research published in the journal Postgraduate Medicine, "How are human papillomavirus (HPV), cervical cancer, and the recently developed HPV vaccines associated with each other? Human papillomavirus is a highly prevalent...

Researchers from Yale University, Medical Department detail findings in cancer vaccines.
November 3, 2008... According to recent research published in the journal Clinical and Vaccine Immunology, "We are developing recombinant attenuated vesicular stomatitis virus (VSV) as a vaccine vector to generate humoral and cell-mediated immune responses. Here,...

Studies from M. Barve and colleagues reveal new findings on cancer vaccines.
November 3, 2008... " Generation of broad cytotoxic T-lymphocyte responses against multiple epitopes and tumor-associated antigens (TAAs) may provide effective immunotherapy in patients with cancer. We evaluated a single-vial peptide vaccine consisting of nine...

Data on cancer vaccines published by researchers at Harvard University.
November 3, 2008... Data detailed in 'Modeling cervical cancer prevention in developed countries' have been presented. According to recent research published in the journal Vaccine, "Cytology-based screening has reduced cervical cancer mortality in countries able...

Researchers from H. Lee Moffitt Cancer Center describe findings in cancer vaccines.
November 3, 2008... Current study results from the report, 'Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions,' have been published. "Human papillomavirus (HPV) infection is commonly found in the genital tract...

Researchers from National Institutes of Health publish findings in cancer vaccines.
November 3, 2008... Scientists discuss in 'Human papillomavirus infection and the primary and secondary prevention of cervical cancer' new findings in cancer. According to recent research from the United States, "A wealth of evidence has led to the conclusion that...

Research from Catalan Institute of Oncology in cancer vaccines prevention provides new insights.
November 3, 2008... Researchers detail in 'Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia,' new data in cancer vaccines. According to a study from Spain, "Worldwide human papillomavirus...

New data from Cancer Research UK Center for Epidemiology illuminate research in cancer vaccines therapy.
November 3, 2008... Scientists discuss in 'Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries' new findings in cancer vaccines. "Screening for cervical cancer precursors by cytology...

Data on human papillomavirus vaccines described by researchers at Pan American Health Organization.
November 3, 2008... Investigators publish new data in the report 'Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.' "This paper explores different international vaccine financing and...

New human papillomavirus vaccines study findings reported from National Cancer Institute.
November 3, 2008... Fresh data on human papillomavirus are presented in the report 'An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.' According to recent research published in the journal Vaccine, "This review...

Antigenics Submits Oncophage Application for European Approval.
November 3, 2008... Antigenics Inc. (NASDAQ: AGEN) announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) requesting approval for Oncophage(R) in earlier-stage, localized renal cell carcinoma (kidney cancer)...

Biovest Announces $1.6M in Federal Funding Appropriated for Groundbreaking Cancer Vaccine & Skin/Bone/Tissue Repair Research.
November 3, 2008... Biovest International, Inc. (OTCBB:BVTI) announced that the U.S. Federal Government has approved the appropriation of $1.6 million in biomedical research funds for Fiscal Year 2009 for the Defense Department's Cancer Immunotherapy and Cell...

Doctor Recommends New Powerful Natural Antiviral Against the Flu.
November 3, 2008... Dr. Howard Peiper, a Pulitzer prize nominated author, has written numerous books on nutrition and natural health including 12 best sellers. Dr. Peiper is recommending a brand new supplement from a nutraceutical company, ZEO Health Ltd., called...

ERYtech Pharma Proposes New Anticancer Vaccine Technology.
November 3, 2008... ERYtech Pharma, a French biotechnology company, will present very promising results from its original approach on antitumor vaccination at the 6th International Cancer Vaccine Symposium to be held in New York from October 28-30, 2008 (see also...

Data on cancer vaccines reported by C.C. Wang and co-researchers.
November 10, 2008... "Cancer-associated carbohydrate antigens are often found on the surface of cancer cells. Understanding their roles in cancer progression will lead to the development of new therapeutics and high-sensitivity diagnostics for cancers," researchers...

Findings in cancer vaccines reported from H.I. Cho and co-researchers.
November 10, 2008... " Vaccines capable of inducing CD8 T cell responses to antigens expressed by tumor cells are considered as attractive choices for the treatment and prevention of malignant diseases. Our group has previously reported that immunization with...

Hammersmith Hospital reports research in cancer vaccines.
November 10, 2008... According to recent research from London, the United Kingdom, "The graft-versus-leukemia (GVL) effect following allogeneic stem cell transplantation is testament to the effectiveness of the immune system in recognizing and eliminating leukemia...

New cancer vaccines research has been reported by scientists at University of Southampton.
November 10, 2008... "The Wilms tumor antigen, WT1, is associated with several human cancers, including leukemia. We evaluated WT1 as an immunotherapeutic target using our proven DNA fusion vaccine design, p.DOM-peptide, encoding a minimal tumor-derived major...

New cancer vaccines research reported from B.B. Williams and co-authors.
November 10, 2008... According to recent research from Melbourne, Australia, "Overexpression of the proto-oncogene c-Myb occurs in more than 80% of colorectal cancer (CRC) and is associated with aggressive disease and poor prognosis. To test c-Myb as a therapeutic...

Study results from Wayne State University provide new insights into cancer vaccines.
November 10, 2008... According to recent research from the United States, " The development of Her-2 DNA vaccine has progressed through three phases that can be categorized as phase ''A'': the pursuit of Her-2 as a tumor-associated ''antigen'', phase ''B'':...

New human papillomavirus vaccines research from R.P. Insinga et al outlined.
November 10, 2008... "In this article we compare previously published cost-effectiveness studies of human papillomavirus (HPV) vaccines along a defined subset of key model structural assumptions relating to HPV infection and disease, cervical cancer screening and...

Data from Karolinska University advance knowledge in immunotherapy.
November 10, 2008... "Evidence for the existence of CLL-specific antigens recognized by the immune system can be gathered from the observation that many patients display monoclonal or oligoclonal expansions and skewed repertoire of T cells. In vitro functional...

Studies from University of Louisville add new findings in the area of life sciences.
November 10, 2008... "B cells are antibody (Ab)-secreting cells as well as potent antigen (Ag)-presenting cells that prime T-cell activation, which evokes great interest in their use for vaccine development. Here, we targeted ovalbumin (OVA) to B cells via CD19 and...

Researchers from Memorial Sloan Kettering Cancer Center describe findings in cancer vaccines.
November 10, 2008... Current study results from the report, 'Peptide vaccines for myeloid leukaemias,' have been published. "The development of cancer vaccines directed against myeloid leukaemias has been a research area of intense interest in the past decade. Both...

Scientists at St. James's Hospital publish research in cancer vaccines.
November 10, 2008... Scientists discuss in 'Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model' new findings in cancer. "We evaluated the...

Scientists at University of Alberta discuss research in cancer vaccines.(Report)
November 10, 2008... New investigation results, 'Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity,' are detailed in a study published in Vaccine. According to a...

Scientists at University of Pennsylvania detail research in cancer vaccines.(Report)
November 10, 2008... Researchers detail in 'Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques,' new data in cancer. According to recent research from the United States, "Human...

Data on immunization published by investigators at Research Center.
November 10, 2008... Data detailed in 'Diterpenes drive Th1 polarization depending on IL-12' have been presented. According to recent research published in the journal International Immunopharmacology, "Sandaracopimaric acid and Sandaracopimaradiene-3beta-ol are...

Scientists at Sanofi Pasteur report research in immunization.
November 10, 2008... A new study, 'Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells,' is now available. "The recombinant canarypox virus ALVAC is being extensively studied as vaccine vector for the development of new vaccine...

Studies from University of Pennsylvania, Abramson Family Cancer Research Institute have provided new data on life sciences.
November 10, 2008... Current study results from the report, 'Post-transplant adoptive T-cell immunotherapy,' have been published. "Immune reconstitution following haematopoietic stem cell transplantation (SCT) is an often slow and incomplete process that leads to...

New ovarian cancer research from J. Clarke and co-researchers described.
November 10, 2008... A new study, 'Assuring the quality of quality assurance: seeding abnormal slides into the negative Papanicolaou smears that will be rapid rescreened,' is now available. "Rapid rescreening (RR) of negative Papanicolaou smears (PS) is used in...

Opening Dedication of the New John G. Rangos Sr. Research Center at the New Children's Hospital of Pittsburgh of UPMC Campus in Lawrenceville.
November 10, 2008... Children's Hospital of Pittsburgh of UPMC officially opened its new 10-story, state-of-the-art John G. Rangos Sr. Research Center today marking the first completed phase of its new premier pediatric campus (see also Biomedicine). With more...

Data Demonstrate ORENCIA abatacept Improves Health-Related Quality of Life, Pain and Sleep Quality in Children With Juvenile Idiopathic Arthritis.(Clinical report)
November 10, 2008... Bristol-Myers Squibb Company (NYSE: BMY) announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA(R) (abatacept), compared to placebo,...

Study Results Demonstrate More Patients With Early Erosive Rheumatoid Arthritis Treated With ORENCIA abatacept and Methotrexate MTX Achieved DAS28 CRP-Defined Remission Compared to MTX Alone.(Clinical report)
November 10, 2008... Bristol-Myers Squibb Company (NYSE: BMY) announced results from a Phase IIIb study in adult patients with early moderate-to-severe erosive rheumatoid arthritis (RA) who had never received previous methotrexate (MTX) treatment. This study showed...

Cancer vaccine shows promise in patients with bowel, kidney and prostate cancer.
November 10, 2008... Analysis of data from several phase I and II clinical trials of a new cancer vaccine has shown it is capable of eliciting an immune response in most patients with bowel, kidney and prostate cancer, and that it may provide clinical benefit (see...

Vaxine Makes Unsolicited Bid to Acquire U.S. Company Protein Sciences Corporation.
November 10, 2008... Vaxine Pty Ltd announced that it made an unsolicited bid to acquire Protein Sciences Corporation, a privately-held vaccine company located in Meriden, Connecticut USA. The terms of the proposed offer were not disclosed but include a stock for...

Research indicates need for effective HPV vaccine for women and men and a simple HPV screening test.
November 17, 2008... A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator (see also...

Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms.
November 17, 2008... Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced the publication of a new study in Nature Medicine by scientists from the University of Bonn in collaboration with Alnylam. The new pioneering research...

National Cancer Institute details research in cancer vaccines.
November 17, 2008... "We compared two consensus primer PCR human papillomavirus (HPV) genotyping methods for the detection of individual HPV genotypes and carcinogenic HPV genotypes as a group, using a stratified sample of enrollment cervical specimens from...

New cancer vaccines research from P. Pisani and colleagues discussed.(Report)
November 17, 2008... "Helicobacter bilis DNA has been detected in human tissue and is a candidate for etiologic investigations on the causes of hepatic and biliary tract diseases, but reliable serologic tests need to be developed in order to pursue such...

Studies from National Heart, Lung, & Blood Institute yield new information about cancer vaccines.
November 17, 2008... According to recent research published in the journal Leukemia, "The cure of chronic myeloid leukemia (CML) patients following allogeneic stem cell transplantation (SCT) is attributed to graft-versus-leukemia (GVL) effects targeting...

New DNA research from University of Pittsburgh discussed.
November 17, 2008... "Dendritic cells (DC) are potent antigen-presenting cells that hold promise as cell-based therapeutic vaccines for infectious diseases and cancer. Ideally, DC would be engineered to express autologous viral or tumor antigens to ensure the...

Research from M.L. Tornesello and co-authors provides new data about human papillomavirus.(Report)
November 17, 2008... "Human papillomaviruses (HPVs) are the cause of cervical intraepithelial neoplasia and invasive carcinomas of the uterine cervix. The distribution of specific HPV genotypes varies greatly across populations and HPV surveys have been performed...

Study findings from E.H. Tay et al provide new insights into immunization.(Clinical report)
November 17, 2008... In this recently published study, investigators in Singapore, Singapore conducted a study "To evaluate results of three phase 3 clinical trials of quadrivalent HPV 6/11/16/18 vaccination of young Asia-Pacific women. A total of 814 women from...

Data on cancer vaccines described by researchers at Singapore General Hospital.
November 17, 2008... Investigators publish new data in the report 'Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.' "Hong Kong, Singapore and Taiwan are three island states that are...

Data on cancer vaccines detailed by researchers at Royal Women's Hospital.(Report)
November 17, 2008... New research, 'Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention,' is the subject of a report. According to recent research from Melbourne, Australia, "The region encompassing...

Data on cancer vaccines published by researchers at Peking Union Medical College, Medical College.
November 17, 2008... Data detailed in 'Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia' have been presented. According to recent research published in the journal Vaccine, "To develop a comprehensive intervention policy...

Data on cancer vaccines reported by researchers at Royal Women's Hospital.
November 17, 2008... Fresh data on cancer are presented in the report 'Recommendations for cervical cancer prevention in Asia Pacific.' "Asia Oceania includes countries from both the Asia Pacific region and Australasia, which cover very diverse geographical areas...

New data from K. Cuschieri et al illuminate research in cancer vaccines.
November 17, 2008... A report, 'Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia,' is newly published data in Cancer Epidemiology, Biomarkers & Prevention. According to a study from the United Kingdom,...

New findings from University of Oxford describe advances in cancer vaccines.
November 17, 2008... Scientists discuss in 'Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region' new findings in cancer vaccines. According to recent research published in the journal Vaccine, "We...

Research on cancer vaccines described by scientists at City of Hope Cancer Center.(Report)
November 17, 2008... New research, 'A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models,' is the subject of a report. "Transgenic (Tg) mice expressing HLA class I alleles and lacking murine MHC...

Research on cancer vaccines detailed by scientists at Roswell Park Cancer Institute.
November 17, 2008... Data detailed in 'Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma' have been presented. "Survivin is a tumor-associated antigen (TAA) that has significant...

Research on cancer vaccines reported by scientists at Osaka University.(Report)
November 17, 2008... Current study results from the report, 'Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity,' have been published. According to recent research published in the journal Cancer...

Researchers from Harvard University report on findings in cancer vaccines.
November 17, 2008... Researchers detail in 'Mathematical models of cervical cancer prevention in the Asia Pacific region,' new data in cancer. "Using population-based and epidemiologic data for 25 countries in Asia (22 GAVI-Alliance eligible countries, Thailand,...

Researchers from International Agency for Research on Cancer describe findings in cancer vaccines.
November 17, 2008... Current study results from the report, 'Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal,' have been published. "Although one-third of the world cervical cancer burden is endured in India,...

Researchers from Jichi Medical University, Department of Gynecology publish findings in cancer vaccines.
November 17, 2008... Scientists discuss in 'Human papillomavirus infection and cervical cancer prevention in Japan and Korea' new findings in cancer. According to recent research from Omiya, Japan, "Cervical cancer is a common cancer among women in Japan and Korea....

Researchers from University Hospital detail findings in cancer vaccines.
November 17, 2008... A new study, 'Amino acid-modified calcitonin immunization induces tumor epitope-specific immunity in a transgenic mouse model for medullary thyroid carcinoma,' is now available. According to a study from Germany, "Up to now, no relevant tumor...

Scientists at Center of Molecular Immunology discuss research in cancer vaccines.
November 17, 2008... New investigation results, 'Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge,' are detailed in a study published in Cancer Immunology,...

Scientists at Charite University describe research in cancer vaccines.(Report)
November 17, 2008... Research findings, 'HLA typing demands for peptide-based anti-cancer vaccine,' are discussed in a new report. "Immunological treatment of cancer has made some very promising advances during the last years. Anti-cancer vaccination using peptides...

Scientists at Walter Reed Army Medical Center, Department of Surgery detail research in cancer vaccines.
November 17, 2008... Researchers detail in 'Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group...

Scientists at Herlev University, Department of Hematology publish research in cancer vaccines immunotherapy.
November 17, 2008... Scientists discuss in 'RhoC a new target for therapeutic vaccination against metastatic cancer' new findings in cancer vaccines. "Most cancer deaths are due to the development of metastases. Increased expression of RhoC is linked to enhanced...

Advaxis Inc. to Present at the 7th Annual BIO Investor Forum.
November 17, 2008... Tom Moore, CEO of Advaxis, Inc. (OTCBB: ADXS, http://www.advaxis.com), will present at the 7th Annual BIO Investor Forum. The conference is being held at the Palace Hotel in San Francisco, October 29-31, 2008. Advaxis' presentation is scheduled...

Canopus Biopharma Announces Positive Results In Human Study of Novel Peptide Cancer Vaccine.
November 17, 2008... Canopus BioPharma, Inc. (OTC: CBIA; www.canopusbiopharma.com) announced that it has successfully completed the second phase of its cancer vaccine development. The specialized laboratory study was analyzed at the Southern Research Institute...

Lung Cancer Alliance Releases 4th Annual Report Card on Lung Cancer.
November 17, 2008... For the fourth year in a row, Lung Cancer Alliance (LCA) marked the start of Lung Cancer Awareness Month with the release of its "Report Card on Lung Cancer", a national assessment of progress being made in the fight against lung cancer. For...

PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies.
November 17, 2008... PDS Biotechnology Corporation announced that the company has been selected as a collaborator of the US National Cancer Institute's Nanotechnology Characterization Lab (NCL) to complete preclinical development of Versamune(TM)-HPV prior to...

Celldex Presents Results from Phase 1 Studies of CDX-1307 with GM-CSF.
November 17, 2008... Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced initial results from multi-center Phase 1 clinical trials of its cancer vaccine candidate, CDX-1307, combined with GM-CSF, at the International Society for the Biologic Therapy of Cancer...

Two new dosage strengths of Stalevo[R] approved in the U.S. provide greater dosing flexibility for people with Parkinsons disease.
November 17, 2008... Novartis Pharmaceuticals Corporation announced the launch of two new FDA-approved dosage strengths of Stalevo[R] (carbidopa, levodopa and entacapone), which is indicated for certain people with Parkinson's disease who experience end-of-dose...

Chronic inflammation can help nurture skin cancer, study shows.
November 17, 2008... Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found (see also Medical College of Georgia). IDO, an enzyme that works like a firefighter to keep inflammation under control,...

Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients.
November 17, 2008... Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia (see...

Protein-printing technique gives snapshots of immune system defense.
November 17, 2008... When Albrecht Durer and other Renaissance artists painstakingly etched images onto plates, swabbed ink into the fine grooves and transferred the images to paper with a press, they never could have guessed that centuries later the same technique...

LSUHSC public health contributes to estimate of HPV-related cancers.
November 24, 2008... Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most...

Research in the area of cancer vaccines reported from University of California.
November 24, 2008... "Therapeutic vaccination of B cell lymphoma patients with tumor-specific Ig (idiotype, or Id) chemically coupled to the immunogenic foreign carrier protein keyhole limpet hemocyanin (KLH) using glutaraldehyde has shown promising results in...

Scientists at University of Pennsylvania, Medical Department detail research in cancer vaccines.
November 24, 2008... "The high molecular weight melanoma-associated antigen (HMW-MAA), also known as melanoma chondroitin sulfate proteoglycan, has been used as a target for the immunotherapy of melanoma. This antigen is expressed on the cell surface and has a...

Study findings from University of Pittsburgh, Medical Department provide new insights into life sciences.
November 24, 2008... "Bone marrow-derived dendritic cells engineered using recombinant adenovirus to secrete high levels of IL-12p70 dramatically inhibited the growth of established CMS4 sarcomas in BALB/c mice after intratumoral administration. An analysis of...

Hepatitis C May Increase Risk for Kidney Cancer.
November 24, 2008... Physicians at Henry Ford Hospital have found that chronic hepatitis C, an inflammation of the liver caused by a viral infection, may increase the risk for kidney cancer (see also Cancer Vaccines). Using administrative data from Henry Ford...

TNFerade Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer.
November 24, 2008... GenVec, Inc. (Nasdaq:GNVC) announced that TNFerade(TM) has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for its proposed use in the treatment of locally advanced pancreatic cancer. The designation...

Tekturna[R], first approved direct renin inhibitor, effectively lowers high blood pressure in elderly patients.
November 24, 2008... New clinical data presented today show the first approved direct renin inhibitor Tekturna[R] (aliskiren) provides effective blood pressure reductions in patients with high blood pressure aged 65 and older. In the AGELESS study, Tekturna lowered...

ImmunoCellular Therapeutics Presents Data Demonstrating Immune Response Targeting Cancer Stem Cells.
November 24, 2008... ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC)(IMUC), a biotechnology company, presented data showing an immunological response against cancer stem cells (CSCs) derived from brain cancer, specifically glioblastoma. It has been demonstrated in...

NaturalNews Launches Print-On-Demand, Publishing Services for Book Authors, Self Publishers.
November 24, 2008... Natural health news site NaturalNews.com has announced the launch of print-on-demand and publishing services that allow authors and alternative information writers to produce small batches of perfect-bound books up to 400 pages in length. In...